WHO: Vira Health was founded in 2020 by Andrea Berchowitz and Rebecca Love with the mission to make high-quality personalized menopause care accessible to all women. Stella, the first product from Vira Health, is a personalized app for menopause relief.
WHY: The funding will be used to invest further in product development and to expand the team.
IN THEIR OWN WORDS: "At Vira, our vision is to fundamentally transform long term health and wellbeing for women. We believe better menopause care is the first step. Female health issues have historically been under-researched and under-invested, and this remains the case today. There is an opportunity to use technology to redress this balance by improving the collection and use of female data in healthcare. This first round of seed funding is a step towards realizing our vision," said Dr Rebecca Love, co-founder, Vira Health.
Remus Brett, investment partner, LocalGlobe, said, "Menopause represents a major phase of a woman's life and the current healthcare system struggles to provide the multi-faceted and long-term support that women need. We are thrilled to back the Vira team on their vision for personalised, science-backed support and treatment. We've been extremely impressed by the evidence-based and user-focused approach Andrea and Rebecca have adopted, and we believe this positions them to build a category leader."
Alexia Arts, investor, MMC Ventures, said: "At MMC Ventures, healthcare is a key area of research and investment. We see a huge potential in capturing and harnessing data insights to reshape the way that healthcare is practised and delivered. This is particularly relevant in female healthcare where there is a well documented gender data gap that needs to be addressed. Andrea, Rebecca and the wider team at Vira Health have the passion, expertise and vision to transform the provision of healthcare and long term health outcomes for women, starting with menopause. We're delighted to be partnering with them in the months and years ahead."
DETAILS:
